Expansion of CD133-expressing liver cancer stem cells in liver-specific phosphatase and tensin homolog deleted on chromosome 10-deleted mice.
about
Carcinogenic effects of "whole-life" exposure to inorganic arsenic in CD1 miceRenal Cancer Stem Cells: Characterization and Targeted TherapiesThe Progress and Prospects of Putative Biomarkers for Liver Cancer Stem Cells in Hepatocellular CarcinomaStem-like plasticity and heterogeneity of circulating tumor cells: current status and prospect challenges in liver cancerReciprocal regulation by TLR4 and TGF-β in tumor-initiating stem-like cells.Computational identification of hepatitis C virus associated microRNA-mRNA regulatory modules in human livers.Celecoxib suppresses hepatoma stemness and progression by up-regulating PTEN.Epigenetic regulation of cancer stem cell marker CD133 by transforming growth factor-beta.Transient mTOR inhibition facilitates continuous growth of liver tumors by modulating the maintenance of CD133+ cell populations.Circulating tumor and cancer stem cells in hepatitis C virus-associated liver disease.Mechanisms underlying the cytotoxicity of a novel quinazolinedione-based redox modulator, QD232, in pancreatic cancer cellsNovel therapeutic strategies for targeting liver cancer stem cells.Foxl1-Cre-marked adult hepatic progenitors have clonogenic and bilineage differentiation potentialTGF-β signaling alters the pattern of liver tumorigenesis induced by Pten inactivation.Antibody approaches to prepare clinically transplantable cells from human embryonic stem cells: identification of human embryonic stem cell surface markers by monoclonal antibodies.Induction of tumor initiation is dependent on CD44s in c-Met⁺ hepatocellular carcinomac-Met represents a potential therapeutic target for personalized treatment in hepatocellular carcinomaIsolation of CD133+ liver stem cells for clonal expansionCell-surface Vimentin: A mislocalized protein for isolating csVimentin(+) CD133(-) novel stem-like hepatocellular carcinoma cells expressing EMT markers.Stem cells in liver diseases and cancer: recent advances on the path to new therapies.The EGFR/ErbB3 Pathway Acts as a Compensatory Survival Mechanism upon c-Met Inhibition in Human c-Met+ Hepatocellular Carcinoma.Epigenetic regulation of cancer stem cells in liver cancer: current concepts and clinical implications.Therapeutics targeting CD90-integrin-AMPK-CD133 signal axis in liver cancer.Toll-like Receptor 4 on Macrophage Promotes the Development of Steatohepatitis-related Hepatocellular Carcinoma in Mice.Progress in stem cell-derived technologies for hepatocellular carcinoma.Single-cell clones of liver cancer stem cells have the potential of differentiating into different types of tumor cells.Human osteosarcoma CD49f(-)CD133(+) cells: impaired in osteogenic fate while gain of tumorigenicity.Cancer stem cells: problems for therapy?Role of cancer stem cells in hepatocarcinogenesis.The molecular pathogenesis and clinical implications of hepatocellular carcinoma.The emerging role of the phosphatidylinositol 3-kinase/ akt/mammalian target of rapamycin signaling network in cancer stem cell biology.Wnt/β-catenin activation and macrophage induction during liver cancer development following steatosis.The Implications and Future Perspectives of Nanomedicine for Cancer Stem Cell Targeted Therapies.Expression kinetics of hepatic progenitor markers in cellular models of human liver development recapitulating hepatocyte and biliary cell fate commitment.Lupeol targets liver tumor-initiating cells through phosphatase and tensin homolog modulation.Expansion of hepatic tumor progenitor cells in Pten-null mice requires liver injury and is reversed by loss of AKT2.The C-terminus domain of the hepatitis B virus x protein stimulates the proliferation of mouse foetal hepatic progenitor cells, although it is not required for the formation of spheroids.PI3K/AKT signaling regulates bioenergetics in immortalized hepatocytes.Alcohol Increases Liver Progenitor Populations and Induces Disease Phenotypes in Human IPSC-Derived Mature Stage Hepatic CellsAdaptive basal phosphorylation of eIF2α is responsible for resistance to cellular stress-induced cell death in Pten-null hepatocytes.
P2860
Q24707869-C4D76089-7A87-4FD3-9199-B3CC053ED81FQ26746970-584A5E93-0AB6-46A0-82C7-488216999864Q28071619-8232B584-B805-4A4D-B1B3-3A116CD4618AQ28079205-030055CC-1B4B-4C9B-B55A-42A1213EF77CQ30540998-52BC7156-800B-457D-9E2C-51B237A7A8A1Q33492595-EDB20901-E698-441A-9CB7-F5443567E4EBQ33688897-C3A94E1D-7320-439E-ACB6-441BE4C59EC1Q33820694-733CDFC9-7B2A-4712-9DF5-E162DDDAA08AQ34092485-F1C8A6B9-6123-491C-B8EB-012A9F2A2986Q34779133-05995879-2B01-469F-8256-16DB3C086ABFQ34795689-564E6526-6A71-4697-9BCA-CD43B2019F18Q34940971-49DDBFA0-6ECC-46C3-B48F-956719446D30Q35033882-D388170B-9901-4F7B-A98B-BD4EC6107E0DQ35097226-E666F383-A898-444E-9B55-3D5E6E7C6815Q35116982-CAFA8C00-92F8-4079-9EBE-D05D10ACDBB6Q35234688-F7C8F340-68F9-4D1C-9D5F-4EF8E4B242C6Q35235798-8B805962-7942-4AA5-86C8-48F3CBC09165Q35581775-55936E4C-8AAA-4485-9868-25C73265B926Q35598363-532BFA6C-CDC2-4293-95EA-552D8D2425E5Q35631841-2C3EA19F-2E87-4B1C-8F24-398E7248EAA7Q35636713-BEDFDAA3-731D-4F4E-B993-9A4FE7E55B8BQ36382605-EACE9F99-77CB-4C87-AC32-727C86067605Q36619069-D0726B2F-FA94-4789-8773-1A91E4F3513EQ36941050-72BFBF3C-7E61-41A1-B50C-DBA463E88B85Q37194065-F633B6CA-BBBC-4E2B-85DB-A17014D769BAQ37299588-C6EE2D38-6605-4EA0-A747-CAFC70B94308Q37626756-80F428EB-9B5C-40DD-AE8F-FA785708EFAAQ37815127-60433C3B-AD5B-4596-8AAB-EF9658D1106FQ37846254-C45CBA69-33C4-431B-9367-62C5E4229027Q37970351-0222BA7F-516F-4C00-A6AD-26870E76B1ACQ38166578-D6CC2107-432F-4F35-BCC2-D3C40C87CF48Q38431732-3B8D6BC7-902F-4861-92ED-C03AA7050B17Q38645695-5EACCB14-43D7-4053-A5A3-798AC8461FE4Q38844070-89F9190E-DC09-4102-BBDD-58E9F5D97E3FQ39639351-E2319BDC-AFB6-48C0-8182-835F270BBB62Q39656536-AF2B33BD-3908-4568-A592-F6D941C5201AQ40154855-B078429A-D4DD-4127-89D2-15DC8AFC9AFFQ40705320-67B2EAA6-FE32-4ED5-83A6-DA74D562DB9EQ41225238-E4FBBA66-D625-4116-8FAE-F372456ECBC0Q42496198-852EA6D8-D9D2-4FCD-929E-E1859BB05B9A
P2860
Expansion of CD133-expressing liver cancer stem cells in liver-specific phosphatase and tensin homolog deleted on chromosome 10-deleted mice.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Expansion of CD133-expressing ...... on chromosome 10-deleted mice.
@en
Expansion of CD133-expressing ...... on chromosome 10-deleted mice.
@nl
type
label
Expansion of CD133-expressing ...... on chromosome 10-deleted mice.
@en
Expansion of CD133-expressing ...... on chromosome 10-deleted mice.
@nl
prefLabel
Expansion of CD133-expressing ...... on chromosome 10-deleted mice.
@en
Expansion of CD133-expressing ...... on chromosome 10-deleted mice.
@nl
P2093
P2860
P1433
P1476
Expansion of CD133-expressing ...... on chromosome 10-deleted mice.
@en
P2093
Bangyan Stiles
C Bart Rountree
P2860
P304
P356
10.1634/STEMCELLS.2008-0332
P577
2009-02-01T00:00:00Z